|
1
|
Massilamany C, Huber SA, Cunningham MW and
Reddy J: Relevance of molecular mimicry in the mediation of
infectious myocarditis. J Cardiovasc Transl Res. 7:165–171. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Antoniak S and Mackman N: Coagulation,
protease-activated receptors, and viral myocarditis. J Cardiovasc
Transl Res. 7:203–211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cao Y, Xu W and Xiong S: Adoptive transfer
of regulatory T cells protects against Coxsackievirus B3-induced
cardiac fibrosis. PLoS One. 8:e749552013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shen Y, Xu W, Chu YW, Wang Y, Liu QS and
Xiong SD: Coxsackievirus group B type 3 infection upregulates
expression of monocyte chemoattractant protein 1 in cardiac
myocytes, which leads to enhanced migration of mononuclear cells in
viral myocarditis. J Virol. 78:12548–12556. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lindner D, Li J, Savvatis K, Klingel K,
Blankenberg S, Tschöpe C and Westermann D: Cardiac fibroblasts
aggravate viral myocarditis: Cell specific coxsackievirus B3
replication. Mediators Inflamm. 2014:5195282014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brown RD, Ambler SK, Mitchell MD and Long
CS: The cardiac fibroblast: Therapeutic target in myocardial
remodeling and failure. Annu Rev Pharmacol Toxicol. 45:657–687.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hardie DG: AMPK: Positive and negative
regulation and its role in whole-body energy homeostasis. Curr Opin
Cell Biol. 33:1–7. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stuck BJ, Lenski M, Böhm M and Laufs U:
Metabolic switch and hypertrophy of cardiomyocytes following
treatment with angiotensin II are prevented by AMP-activated
protein kinase. J Biol Chem. 283:32562–32569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang CX, Pan SN, Meng RS, Peng CQ, Xiong
ZJ, Chen BL, Chen GQ, Yao FJ, Chen YL, Ma YD and Dong YG: Metformin
attenuates ventricular hypertrophy by activating the AMP-activated
protein kinase-endothelial nitric oxide synthase pathway in rats.
Clin Exp Pharmacol Physiol. 38:55–62. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie W, Wang L, Dai Q, Yu H, He X, Xiong J,
Sheng H, Zhang D, Xin R, Qi Y, et al: Activation of AMPK restricts
coxsackievirus B3 replication by inhibiting lipid accumulation. J
Mol Cell Cardiol. 85:155–167. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reed LJ and Muench H: A simple method of
estimating fifty percent endpoints. Am J Hyg. 27:493–497. 1938.
|
|
12
|
Liu MY, Wu DL, Liu NH, Meng QW and Meng
FC: 1A and 3D gene sequences of coxsackievirus B3 strain CC:
Variation and phylogenetic analysis. DNA Seq. 19:8–12. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Leipner C, Grün K, Schneider I, Glück B,
Sigusch HH and Stelzner A: Coxsackievirus B3-induced myocarditis:
Differences in the immune response of C57BL/6 and Balb/c mice. Med
Microbiol Immunol. 193:141–147. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chapman NM and Kim KS: Persistent
coxsackievirus infection: Enterovirus persistence in chronic
myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol.
323:275–292. 2008.PubMed/NCBI
|
|
15
|
Pankuweit S and Klingel K: Viral
myocarditis: From experimental models to molecular diagnosis in
patients. Heart Fail Rev. 18:683–702. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bhattacharjee A and Bansal M: Collagen
structure: The Madras triple helix and the current scenario. IUBMB
Life. 57:161–172. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kasyanov V, Moreno-Rodriguez RA, Kalejs M,
Ozolanta I, Stradins P, Wen X, Yao H and Mironov V: Age-related
analysis of structural, biochemical and mechanical properties of
the porcine mitral heart valve leaflets. Connect Tissue Res.
54:394–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu WY and Jiang RS: Advances in the
research of AMPK and its subunit genes. Pak J Biol Sci.
16:1459–1468. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao B, Sanders MJ, Underwood E, Heath R,
Mayer FV, Carmena D, Jing C, Walker PA, Eccleston JF, Haire LF, et
al: Structure of mammalian AMPK and its regulation by ADP. Nature.
472:230–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baron SJ, Li J, Russell RR III, Neumann D,
Miller EJ, Tuerk R, Wallimann T, Hurley RL, Witters LA and Young
LH: Dual mechanisms regulating AMPK kinase action in the ischemic
heart. Circ Res. 96:337–345. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma Y, Wang J, Gao J, Yang H, Wang Y,
Manithody C, Li J and Rezaie AR: Antithrombin up-regulates
AMP-activated protein kinase signalling during myocardial
ischaemia/reperfusion injury. Thromb Haemost. 113:338–349. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Chen C, Yao F, Su Q, Liu D, Xue R,
Dai G, Fang R, Zeng J, Chen Y, et al: AMPK inhibits cardiac
hypertrophy by promoting autophagy via mTORC1. Arch Biochem
Biophys. 558:79–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Beauloye C, Bertrand L, Horman S and Hue
L: AMPK activation, a preventive therapeutic target in the
transition from cardiac injury to heart failure. Cardiovasc Res.
90:224–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim AS, Miller EJ, Wright TM, Li J, Qi D,
Atsina K, Zaha V, Sakamoto K and Young LH: A small molecule AMPK
activator protects the heart against ischemia-reperfusion injury. J
Mol Cell Cardiol. 51:24–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Paiva MA, Rutter-Locher Z, Gonçalves LM,
Providência LA, Davidson SM, Yellon DM and Mocanu MM: Enhancing
AMPK activation during ischemia protects the diabetic heart against
reperfusion injury. Am J Physiol Heart Circ Physiol.
300:H2123–H2134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li HL, Yin R, Chen D, Liu D, Wang D, Yang
Q and Dong YG: Long-term activation of adenosine
monophosphate-activated protein kinase attenuates
pressure-overload-induced cardiac hypertrophy. J Cell Biochem.
100:1086–1099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gundewar S, Calvert JW, Jha S,
Toedt-Pingel I, Ji SY, Nunez D, Ramachandran A, Anaya-Cisneros M,
Tian R and Lefer DJ: Activation of AMP-activated protein kinase by
metformin improves left ventricular function and survival in heart
failure. Circ Res. 104:403–411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamazaki KG, Gonzalez E and Zambon AC:
Crosstalk between the renin-angiotensin system and the advance
glycation end product axis in the heart: Role of the cardiac
fibroblast. J Cardiovasc Transl Res. 5:805–813. 2012. View Article : Google Scholar : PubMed/NCBI
|
